In consistence with previous study, we found that the optimal cutoff level of relative changes of hs-cTnT were higher in patients with low eGFR and preexisting CAD than those with low eGFR and without preexisting CAD (17.8 versus 16%) (Table 6). This evidence concerns the gene TNNT2 and coronary artery disorder.